February 21, 2023
Another great event by Recipharm organized by Helen Domeshek,PhD! Thank you for this fun and informative evening 🍻 Great opportunity to discuss with colleagues and friends about #fundraising #ipo #croudfunding #bussinessdevelopment and more! Great job by our CEO Dr. Lior Shaltiel, PhD telling NurExone Biologic‘s story Read More …
Join us at Dublin Pub, Rehovot on Wednesday, 14th of December, to hear our CEO Dr. Lior Shaltiel, PhD share insights about #IPO, #funding at the #healthtech industry and more…! Read More…
Good job for Dr. Lior Shaltiel, PhD and Inbar Paz Benayoun, Adv. for the successful and effective business trip to London last week! Representing the company in an OTC Markets Group event and exploring new opportunities and collaborations! Read More …
Last month NurExone Biologic was hosting an investor webinar through Thesis Capital Inc. to discuss its recent business highlights and growth outlook. You can now watch the webinar with caption. Part 1 | Part 2
NurExone Biologic team members Lior Shaltiel, PhD, Lyora Aharonov and Inbar Paz Benayoun, Adv. at the MIXiii Health-Tech.IL in Jerusalem. It has been a pleasure to hear recent developments and network in the Life Science & health tech community! Read More…
NurExone Biologic team will be participating the MIXiii Health-Tech.IL conference as a leading Life-Science publicly traded company! Read More…
In Heath Tech World’s latest roundtable in a series of events we hear from leading experts in the SCI community. Read More
Please welcome Dr Lior Shaltiel, CEO and director at NurExone Biologic, to our panel of experts for the ‘Ending Paralysis’ Roundtable on October 13th. Read More
NurExone Biologic Inc. Will Be Hosting An Investor Webinar Thursday, October 20th 11.00 AM (EST) | 17.00 (CET) | 18.00 (Israel Time) Read More